Literature DB >> 19615918

Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors.

Mong-Wei Lin1, Yih-Leong Chang, Pei-Ming Huang, Yung-Chie Lee.   

Abstract

OBJECTIVE: While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy.
METHODS: A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken.
RESULTS: There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p=0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p=0.003), age <40 years (p=0.022) and the presence of thymic hyperplasia (p=0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p=0.91, 95% confidence interval (CI)=0.27-3.21) were not statistically relevant to better remission rate.
CONCLUSIONS: VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy. Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19615918     DOI: 10.1016/j.ejcts.2009.05.027

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  19 in total

Review 1.  Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes.

Authors:  Nicholas R Hess; Inderpal S Sarkaria; Arjun Pennathur; Ryan M Levy; Neil A Christie; James D Luketich
Journal:  Ann Cardiothorac Surg       Date:  2016-01

Review 2.  Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.

Authors:  Kai Zhu; Jiaoxing Li; Xin Huang; Wei Xu; Weibin Liu; Jiaxin Chen; Pei Chen; Huiyu Feng
Journal:  Neurol Sci       Date:  2017-07-13       Impact factor: 3.307

3.  Thymectomy for myasthenia gravis: what's next?

Authors:  Marc de Perrot; Laura Donahoe
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 4.  Myasthenia gravis: an update for the clinician.

Authors:  J P Sieb
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 5.  Is thymectomy in non-thymomatous myasthenia gravis of any benefit?

Authors:  Andres Diaz; Edward Black; Joel Dunning
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-18

6.  Preliminary results of VATS thymectomy for pediatric myasthenia gravis.

Authors:  Ketan Parikh; Amrish Vaidya; Rajesh Jain
Journal:  Pediatr Surg Int       Date:  2011-06       Impact factor: 1.827

7.  Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis.

Authors:  Jinwei Zhang; Yuan Chen; Hui Zhang; Zhaoyu Yang; Peng Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-05-20       Impact factor: 4.123

8.  A comparison of three approaches for the treatment of early-stage thymomas: robot-assisted thoracic surgery, video-assisted thoracic surgery, and median sternotomy.

Authors:  Liqiang Qian; Xiaoke Chen; Jia Huang; Hao Lin; Feng Mao; Xiaojing Zhao; Qingquan Luo; Zhengping Ding
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

9.  Clinical Outcomes of Myasthenia Gravis with Thymoma and Thymic Hyperplasia Undergoing Extended Transsternal Thymectomy: A Single-Center Experience.

Authors:  Surena Nazarbaghi; Mohammad Reza Amiri-Nikpour; Rahim Mahmodlou; Nasim Arjmand; Yousef Rezaei
Journal:  N Am J Med Sci       Date:  2015-11

10.  Surgical approaches for stage I and II thymoma-associated myasthenia gravis: feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy in comparison with trans-sternal resection.

Authors:  Zhicheng He; Quan Zhu; Wei Wen; Liang Chen; Hai Xu; Hai Li
Journal:  J Biomed Res       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.